Seed VC · Luxembourg
Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients, specializing exclusively in therapeutics for oncology and genetic disease. The firm actively supports companies from creation through clinical proof of concept, focusing on breakthrough therapies with material impact on patient prognosis.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Biotech Companies
Geography
US, Europe, APAC
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Droia Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Droia Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Amazon Industrial Innovation Fund
DeepTech, AI, Electronics
Seed VC
AME Cloud Ventures
DeepTech, AI, Data
Seed VC
America's Frontier Fund (AFF)
DeepTech, Aerospace, AI
Seed VC
Amiti Capital
DeepTech, AI, Electronics
Seed VC
Amplify Partners
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
Amplitude Ventures
DeepTech, Healthtech, Biotech
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Droia Ventures is one of them, and we'll tell you exactly where they sit in your top 100.